Skip to content
Screener

Inspire Medical Systems INSP Business Segments — Operating Income (Loss)

Similar metrics at other companies

Charles River Laboratories logo
CRLSegment operating income — Operating Income (Loss)
$226.28M+32.6%
Enerpac Tool Group logo
EPACOther Operating Segment — Operating Income (Loss)
$2.07M-0.5%
Public Storage logo
PSAAncillary operations — Operating Income (Loss)
$56.65M+15.3%
NiSource logo
NINIPSCO Operations — Operating Income (Loss)
$120.4M-10.1%
Tejon Ranch logo
TRCRanch operations — Operating Income (Loss)
-$93K+63.1%
NiSource logo
NIColumbia Operations — Operating Income (Loss)
$103.3M-15.5%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Cost of goods sold27,67130,709
Research and development expense25,82627,803
Selling, general and administrative expense (excluding advertising expense)130,558123,349
Advertising expense21,64620,941
Operating (loss)(1,118)(1,485)
Other income (b)(3,515)(5,644)
Income tax expense13,6911,167
Net (loss) earnings$(11,294)$2,992

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's business segments — operating income (loss)?
Inspire Medical Systems (INSP) reported business segments — operating income (loss) of -$1.12M in Q1 2026.
How has Inspire Medical Systems's business segments — operating income (loss) changed year-over-year?
Inspire Medical Systems's business segments — operating income (loss) increased by 24.7% year-over-year, from -$1.49M to -$1.12M.
What is the long-term trend for Inspire Medical Systems's business segments — operating income (loss)?
Over 3 years (2022 to 2025), Inspire Medical Systems's business segments — operating income (loss) has grown at a 2.3% compound annual growth rate (CAGR), from -$47.59M to $50.95M.
What does business segments — operating income (loss) mean?
Measures the profitability of the company's core business activities by subtracting operating expenses from total revenue. It indicates the operational health and efficiency of the business before accounting for financing, taxes, or non-recurring items.

Ask your AI about Inspire Medical Systems's business segments — operating income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude